3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Breast Neoplasms
15
Leukemia
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Chronic-Phase
10
Recurrence
8
Prostatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Melanoma
5
Burkitt Lymphoma
5
Pancreatic Neoplasms
4
Leukemia, Myeloid, Acute
4
Glioblastoma
4
Blast Crisis
4
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Neoplasms
3
Lymphoma
3
Gliosarcoma
3
Sarcoma
2
Salivary Gland Neoplasms
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Polycythemia Vera
2
Oligodendroglioma
2
Multiple Myeloma
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Paclitaxel
6
Radiotherapy
2
Pemetrexed
2
Carboplatin
2
Brachytherapy
2
tucatinib
1
seribantumab
1
osimertinib
1
gedatolisib
1
fosaprepitant
1
fluciclovine F-18
1
cobimetinib
1
atezolizumab
1
alovudine
1
Trastuzumab
1
Therapeutics
1
TP protocol
1
Saline Solution
1
Radiation
1
Protons
1
Palliative Care
1
Nivolumab
1
Letrozole
1
Immunoglobulin G
1
Imatinib Mesylate
1
Ifosfamide
1
Gemcitabine
1
Fulvestrant
1
FANG vaccine
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Neoplasms
×
Dasatinib
×
Clear all
No trials found.